Argitalpenak (38) BEATRIZ RODRÍGUEZ SÁNCHEZ argitalpenak

2025

  1. Economía de la salud, envejecimiento y atención sanitaria a los mayores

    Test para la preparación del EIR en Geriatría (Elsevier), pp. 18-19

2024

  1. Selección adversa y riesgo moral

    Panorama actual del medicamento, Vol. 48, Núm. 473, pp. 583

2023

  1. Association Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults

    JACC: Advances, Vol. 2, Núm. 5

  2. Does becoming an informal caregiver make your health worse? A longitudinal analysis across Europe

    Economics and Human Biology, Vol. 50

  3. Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease

    European Journal of Health Economics, Vol. 24, Núm. 2, pp. 247-277

  4. Predicting the onset of diabetes-related complications after a diabetes diagnosis with machine learning algorithms

    Diabetes Research and Clinical Practice, Vol. 204

2022

  1. Differences in the use of formal and informal care services among older adults after the implementation of the dependency act in Spain

    Hacienda Pública Española / Review of Public Economics, Núm. 240, pp. 61-93

  2. Health economics of diabetic foot disease: Costs of diabetic neuropathy and diabetic foot

    Diabetic Neuropathy (Elsevier), pp. 211-221

  3. Healthcare cost expenditures associated to frailty and sarcopenia

    BMC Geriatrics, Vol. 22, Núm. 1

  4. Métodos de evaluación de políticas públicas

    Papeles de economía española, Núm. 172, pp. 18-29

  5. Otros elementos a valorar en una evaluación económica

    Panorama actual del medicamento, Vol. 46, Núm. 453, pp. 558

  6. Physical performance measures in frailty screening: diagnostic and prognostic accuracy in the Toledo Study of Healthy Ageing

    Maturitas, Vol. 165, pp. 18-25

  7. The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe

    Value in Health, Vol. 25, Núm. 5, pp. 736-743

  8. The employment situation of people living with HIV: a closer look at the effects of the 2008 economic crisis

    European Journal of Health Economics, Vol. 23, Núm. 3, pp. 485-497

  9. ¿Qué es un resultado en salud?

    Panorama actual del medicamento, Vol. 46, Núm. 451, pp. 273

2021

  1. Assessing the effect of including social costs in economic evaluations of diabetes-related interventions: A systematic review

    ClinicoEconomics and Outcomes Research, Vol. 13, pp. 307-334

  2. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis

    Value in Health, Vol. 24, Núm. 3, pp. 431-442

  3. Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease (The European Journal of Health Economics, (2019), 20, 8, (1207-1236), 10.1007/s10198-019-01087-6)

    European Journal of Health Economics

  4. Dependent, poorer, and more care‐demanding? An analysis of the relationship between being dependent, household income, and formal and informal care use in Spain

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 8

  5. Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1